title: Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
abstract: The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous. This study was therefore undertaken to identify subgroups of ASS patients with similar clinico-biological features and outcomes. This retrospective multicentric study included 233 consecutive patients with three different anti-aminoacyl-tRNA-synthetase antibodies (anti-ARS): anti-Jo1 (n=160), anti-PL7 (n=25) and anti-PL12 (n=48). To characterise ASS patients, bivariate, multiple correspondence (MCA), cluster and survival analyses were performed. Interstitial lung disease (ILD) and myositis were the most common ASS manifestations. However, their respective frequencies were correlated to anti-ARS specificity: ILD was more frequent (80% and 88% vs 67%, p=0.014) whereas myositis was less common (44% and 47% vs 74%, p<0.001) in patients with anti-PL7 and anti-PL12 compared to anti-Jo1. The MCA suggested that anti-PL7 and anti-PL12 phenotypes were close to one another and distinct from anti-Jo1. The clustering analysis confirmed these data, identifying subgroups strongly defined by the anti-ARS specificity and other clinical features. Cluster 1 (n=175, 86% of anti-Jo1) defined patients with the most diffuse phenotype, whereas patients from cluster 2 (n=48, 96% of anti-PL12 and anti-PL7) exhibited a disease more restricted to the lung. Patient survival was also conditioned by the anti-ARS specificity, and was significantly lower in patients with anti-PL7/12 rather than anti-Jo1 (p=0.012). Other factors associated with poor survival were mostly related to pulmonary involvement, including severe dyspnea (p=0.003) and isolated ILD (p=0.009) at diagnosis. In patients with ASS, the phenotype and the survival were correlated with the anti-ARS specificity.
authors: Internal Medicine Department 2, French Reference Centre for Lupus, Hôpital Pitié-Salpêtrière, APHP, Paris, France. bhervier@yahoo.fr
authors: Baptiste
authors: B
authors: Hervier
authors: Hervé
authors: H
authors: Devilliers
authors: Raluca
authors: R
authors: Stanciu
authors: Alain
authors: A
authors: Meyer
authors: Yurdagul
authors: Y
authors: Uzunhan
authors: Agathe
authors: A
authors: Masseau
authors: Sylvain
authors: S
authors: Dubucquoi
authors: Pierre-Yves
authors: PY
authors: Hatron
authors: Lucile
authors: L
authors: Musset
authors: Benoit
authors: B
authors: Wallaert
authors: Hilario
authors: H
authors: Nunes
authors: Thierry
authors: T
authors: Maisonobe
authors: Nils-Olivier
authors: NO
authors: Olsson
authors: Daniel
authors: D
authors: Adoue
authors: Philippe
authors: P
authors: Arlet
authors: Jean
authors: J
authors: Sibilia
authors: Marguerite
authors: M
authors: Guiguet
authors: Dominique
authors: D
authors: Lauque
authors: Zahir
authors: Z
authors: Amoura
authors: Eric
authors: E
authors: Hachulla
authors: Mohamed
authors: M
authors: Hamidou
authors: Olivier
authors: O
authors: Benveniste
mesh_terms: D000328:Adult; D000604:Amino Acyl-tRNA Synthetases / Q000276:immunology*; D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology*; D016000:Cluster Analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009220:Myositis / Q000276:immunology* / Q000401:mortality*; D010641:Phenotype; D012189:Retrospective Studies; D012720:Severity of Illness Index
chemical_list: D001323:Autoantibodies; D000604:Amino Acyl-tRNA Synthetases